Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Reach and train: a High-Tech balance test for stroke recovery

NCT ID NCT03994770

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new way to assess and train balance using a reaching task. Seven people, including stroke survivors and healthy adults, took part. They stood and pointed at a moving target on a screen, which challenged their balance. The goal was to see if this method could safely measure and improve balance control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7 people

The number who actually took part.

Started

Nov 2021

Finished

Dec 2023

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-40 years old and in good health; 60 years and older * For Ages 60 or older-stroke with persistent motor function deficit. * For ages 18-40-experienced no falls in the past year. Fall is defined as a fall that occurs under conditions that an able body individual would not fall. * Able to perform the balanced reach task without assistive devices for 90 seconds * Able to perform a sit-to-stand with minimal assistance and walk 10 meters without human assistance * Adequate language and neurocognitive function to give adequate informed consent \& to participate in testing and training * Vision adequate to see a 1 inch diameter black disk against a white background at 3 feet * Able to tolerate the use of Virtual Reality eyewear for \~10 minutes Exclusion Criteria: Clinical history of: * Any health condition that the study team deems would preclude safe completion of the BATP * For ages 18-40-History of a stroke, orthopedic deficits, or sensorimotor deficits * Body Mass Index (BMI) \>40 * Excessive daily alcohol consumption (\>3 oz. liquor; \>12 oz. wine; or \>36 oz. beer) or illicit drug abuse * For ages 60 and older-Dementia based on Montreal Cognitive Assessment (MOCA) score of less than 23 for more than 9th grade education. * Neurological disease other than stroke, such as Parkinson's disease. Vestibular disorders sufficient to preclude safe completion of the BATP or MMBI * Poorly controlled hypertension (\>190/105) on at least two separate occasions * Poorly controlled type 1 or 2 diabetes (HbA1c \>10) * Recent hospitalization for severe disease or surgery (\<3 months) * Congestive heart failure or valvular dysfunction symptomatic with ordinary activities (NYHA II) * Self-reported Pregnancy * Symptomatic orthostatic hypotension

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance deficits are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.